MBOT Straddle Strategy
MBOT (Microbot Medical Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NASDAQ.
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
MBOT (Microbot Medical Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $98.9M, a beta of 1.06 versus the broader market, a 52-week range of 1.6-4.67, average daily share volume of 1.7M, a public-listing history dating back to 1992, approximately 20 full-time employees. These structural characteristics shape how MBOT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.06 places MBOT roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a straddle on MBOT?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current MBOT snapshot
As of May 15, 2026, spot at $1.87, ATM IV 130.60%, IV rank 50.67%, expected move 37.44%. The straddle on MBOT below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on MBOT specifically: MBOT IV at 130.60% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 37.44% (roughly $0.70 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MBOT expiries trade a higher absolute premium for lower per-day decay. Position sizing on MBOT should anchor to the underlying notional of $1.87 per share and to the trader's directional view on MBOT stock.
MBOT straddle setup
The MBOT straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MBOT near $1.87, the first option leg uses a $1.87 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MBOT chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MBOT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $1.87 | N/A |
| Buy 1 | Put | $1.87 | N/A |
MBOT straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
MBOT straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on MBOT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on MBOT
Straddles on MBOT are pure-volatility plays that profit from large moves in either direction; traders typically buy MBOT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
MBOT thesis for this straddle
The market-implied 1-standard-deviation range for MBOT extends from approximately $1.17 on the downside to $2.57 on the upside. A MBOT long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current MBOT IV rank near 50.67% is mid-range against its 1-year distribution, so the IV signal is neutral; the straddle thesis on MBOT should anchor more to the directional view and the expected-move geometry. As a Healthcare name, MBOT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MBOT-specific events.
MBOT straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MBOT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MBOT alongside the broader basket even when MBOT-specific fundamentals are unchanged. Always rebuild the position from current MBOT chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on MBOT?
- A straddle on MBOT is the straddle strategy applied to MBOT (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With MBOT stock trading near $1.87, the strikes shown on this page are snapped to the nearest listed MBOT chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MBOT straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the MBOT straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 130.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MBOT straddle?
- The breakeven for the MBOT straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MBOT market-implied 1-standard-deviation expected move is approximately 37.44%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on MBOT?
- Straddles on MBOT are pure-volatility plays that profit from large moves in either direction; traders typically buy MBOT straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current MBOT implied volatility affect this straddle?
- MBOT ATM IV is at 130.60% with IV rank near 50.67%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.